On August 21, , the U. The major change from the USPSTF guidelines is that for average-risk women aged 30—65 years, the USPSTF now recommends high-risk human papillomavirus hrHPV testing alone every 5 years as an alternative to screening with cervical cytology alone every 3 years or screening with a combination of cytology and hrHPV testing every 5 years. Like the USPSTF recommendations, these expert guidelines recognize that cytology alone, hrHPV testing alone, and co-testing are all effective screening strategies for average-risk women aged 30—65 years. However, expert guidelines recommend that for these women, co-testing with cervical cytology and hrHPV testing every 5 years is preferred, screening with cervical cytology alone every 3 years is acceptable, and hrHPV testing alone can be considered as an alternative screening strategy 4. The new USPSTF recommendations emphasize that the choice of screening strategy should consider the balance of benefit disease detection and potential harms more frequent follow-up testing, invasive diagnostic procedures, and unnecessary treatment in women with false-positive results and involve shared decision making between patients and their health care providers.
|Published (Last):||8 July 2006|
|PDF File Size:||8.75 Mb|
|ePub File Size:||1.58 Mb|
|Price:||Free* [*Free Regsitration Required]|
Obstet Gynecol. Practice Bulletin No. Committee on Practice Bulletins—Gynecology. Collaborators: Chelmow D. In , the rate was By , it decreased to 6. Mortality from the disease has undergone a similar decrease from 5. The American Cancer Society ACS estimated that there would be 12, new cases of cervical cancer in the United States in , with 4, deaths from the disease 2. Cervical cancer is much more common worldwide, particularly in countries without screening programs, with an estimated , new cases of the disease and , resultant deaths each year 3.
When cervical cancer screening programs have been introduced into communities, marked reductions in cervical cancer incidence have followed 4, 5. New technologies for cervical cancer screening continue to evolve, as do recommendations for managing the results.
In addition, there are different risk-benefit considerations for women at different ages, as reflected in age-specific screening recommendations. The purpose of this document is to provide a review of the best available evidence regarding the prevention and early detection of cervical cancer.
ACOG Practice Bulletin Number 131: Screening for cervical cancer.
Obstet Gynecol. Committee on Practice Bulletins—Gynecology. In , the rate was By , it had been reduced to 6. Mortality from the disease has undergone a similar decrease from 5.
Register for a free account
Samulabar Drafting of the manuscript: Accessed December 12, Create a free personal account to download free article PDFs, sign up for alerts, and more. When cervical cancer screening programs have been introduced into communities, marked reductions in cervical cancer incidence have followed 5, 6. Sign in to customize your interests Sign in to your personal account. Back to top Article Information. Sign in to download free article PDFs Sign in to access your subscriptions Sign in to your personal account.
Cervical Cancer Screening (Update)